VeoMed.com to Live Broadcast Ground-Breaking Research on ADHD in Partnership with the American Professional Society for ADHD and Related Disorders
VeoMed.com partners with the American Professional Society for ADHD and Related Disorders to inform medical professionals, and the hundreds of millions of people affected by ADHD, about the ongoing clinical and scientific advances that impact the diagnosis and treatment of ADHD.
Laguna Beach, CA (PRWEB) November 12, 2009 -- VeoMed.com is proud to partner with the American Professional Society for ADHD and Related Disorders (APSARD) to broadcast a unique day-and-a-half program designed to increase medical professionals' awareness of recent research findings that impact the diagnosis and treatment of ADHD. The live broadcast and online discussion of "ADHD--Current Concepts and Future Developments," will begin at 5pm EST on November 13 and continue all day on November 14 on www.VeoMed.com/apsard. VeoMed.com is a leading social media site designed to facilitate better communication, collaboration, and information sharing around pertinent issues in medicine.
Live Broadcast of "ADHD--Current Concepts and Future Developments" on www.VeoMed.com/aspard
The program aims to inform medical professionals, and the hundreds of millions of people affected by ADHD, about the ongoing clinical and scientific advances that have transformed clinicians' understanding of ADHD. This CME-accredited program, "ADHD--Current Concepts and Future Developments," will feature nationally renowned ADHD faculty presenting their research on the neuropathology, neurobiology, heritability, environmental persistence, and co-morbidity of ADHD, and the psychotherapeutic and pharmacological treatment of ADHD in children, adolescents, and adults. ADHD affects approximately three to five percent of children, with symptoms persisting in 75 percent of adolescents and 50 to 60 percent of adults. Approximately 7 million individuals are currently diagnosed with ADHD, however many cases go undiagnosed due to the difficulty in diagnosing the disease.
In addition to being broadcast live on November 13 and 14, this educational event sponsored by an independent medical educational grant from Lilly USA, LLC, and Shire will be available in the future for CME credit on www.VeoMed.com/apsard.
About VeoMed:
VeoMed is a technology company dedicated to democratizing open access and providing the medical community with social media solutions. VeoMed's software powers VeoMed.com, a leading free social media site for healthcare professionals, academic institutions, and medical organizations. VeoMed's social media software blends the best features of YouTube, Facebook, and Twitter into one platform designed to empower the dialogical nature of the internet towards stronger communication, collaboration, and information sharing around pertinent issues in medicine. VeoMed licenses its software for a fee to organizations interested in creating their own online communities and offers a free open access solution to all.
About the American Professional Society of ADHD and Related Disorders
The American Professional Society of ADHD and Related Disorders (APSARD) is an international organization consisting of a broad spectrum of mental health experts and allied healthcare practitioners working to improve the quality of care for patients with ADHD through the exchange of research, best practices and evidence-based insights. APSARD provides practical education and resources to support an effective dialogue about ADHD across the continuum of care, from childhood through adulthood.
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1UaGlyLVN1bW0tSG9yci1FbXB0LVBpZ2ctWmVybw==
|
